Medea Biopharma
PrivateLast Round
Pre Seed
Dec 16, 2024
Total Funding Raised
$3.56M
Company Overview
Medea Biopharma is a biotechnology company that develops bacteriophage-based antimicrobial solutions for therapeutic and non-therapeutic applications in human health, veterinary medicine, and agriculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medea Biopharma Comparables
Compare Medea Biopharma with similar companies based on industry and business-model similarity.
Medea Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 16, 2024 | ||||
| Pre Seed | Dec 1, 2023 | ||||
| Grant | Sep 14, 2023 | ||||
| Accelerator | Jan 1, 2023 |
Medea Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start2 Group | Accelerator |
| TechFounders | Accelerator |
| Singapore Management University's Institute of Innovation & Entrepreneurship | Grant |
Medea Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medea Biopharma's valuation, stock price, and market status.